Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii

25Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

We used bioinformatics approaches to identify B-cell and T-cell epitopes on the ROP19 protein of Toxoplasma gondii. Then, we constructed plasmids with ROP19 (pEGFP-C1-ROP19) and injected them into BALB/c mice to test the immunoprotection induced by this vaccine candidate. The results showed that immunization with pEGFP-C1-ROP19 induced effective cellular and humoral immune responses in mice; specifically, high serum levels of T. gondii-specific IgG and increased interferon-gamma production by splenocytes. Furthermore, the mice vaccinated with pROP19 had significantly fewer brain cysts (583 ± 160) than the mice injected with phosphate-buffered saline (1350 ± 243) or with the control plasmid, pEGFP-C1 (1300 ± 167). Compared with PBS-treated mice, those immunized with pROP19 had only 43% of the number of brain cysts. These results suggest that the DNA vaccine encoding ROP19 induced a significant immune response and provided protection against a challenge with T. gondii strain PRU cysts.

Cite

CITATION STYLE

APA

Zhou, J., Wang, L., Lu, G., Zhou, A., Zhu, M., Li, Q., … He, S. (2016). Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite, 23(4). https://doi.org/10.1051/parasite/2016017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free